Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials

Published:2014-03 Issue:2 Volume:40 Page:271-275
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Iacovelli Roberto,Alesini Daniele,Palazzo Antonella,Trenta Patrizia,Santoni Matteo,De Marchis Laura,Cascinu Stefano,Naso Giuseppe,Cortesi Enrico

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference49 articles.

1. The changing natural history of renal cell carcinoma;Pantuck;J Urol,2001

2. Interferon alpha-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up;Minasian;J Clin Oncol,1993

3. Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer;Parton;J Clin Oncol,2006

4. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer;Yang;N Engl J Med,2003

5. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomized, double-blind phase III trial;Escudier;Lancet,2007

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-Analysis of the Impact of Far-Red Light on Vegetable Crop Growth and Quality;Plants;2024-09-06

2. β-Caryophyllene Inhibits Endothelial Tube Formation by Modulating the Secretome of Hypoxic Lung Cancer Cells—Possible Role of VEGF Downregulation;International Journal of Molecular Sciences;2024-01-09

3. Brachytherapie;PET/CT-Atlas;2024

4. Antitumor mechanism of cannabidiol hidden behind cancer hallmarks;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07

5. Inhibition of Monoacylglycerol Lipase Decreases Angiogenic Features of Endothelial Cells via Release of Tissue Inhibitor of Metalloproteinase-1 from Lung Cancer Cells;Cells;2023-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3